FENC logo

Fennec Pharmaceuticals Inc. (FENC)

Profile

Full Name

Fennec Pharmaceuticals Inc.

Ticker

NASDAQ: FENC

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

September 15, 2017

Indexes

Not included

Website

https://fennecpharma.com

Employees

32

Key Details

Price

$8.45(-3.54%)

Market Cap

$235.18M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$47.54M(123.69% YoY)

Annual EPS

-$0.02(97.35% YoY)

PE Ratio

-

Next earnings date

Nov 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $8.45
    FENC price is $8.45

    30-Day Relative Volume

    1.01
    FENC 30-day relative volume is 1.01

    Price Performance

    Price 1-Day Change

    -3.54%
    FENC price is down -3.54% today

    Price YTD Change

    +33.7%
    FENC price is up +33.7% since January 1st

    Price 1-Year Change

    +76.41%
    FENC price is up +76.41% year-on-year

    Price 3-Year Change

    +0.36%
    FENC price is up +0.36% over the past 3 years

    Price Range

    Price All-Time High

    $14.99
    FENC price is currently -43.61% below its historical high of $14.99

    Price 3-Year Low

    $3.96
    FENC price is currently +113.38% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $235.18M
    FENC market cap is $235.18 million

    Market Cap 3-Year Change

    +6.45%
    FENC market cap is up +6.45% over the past 3 years

    Market Cap All-Time High

    $310.10M
    FENC market cap is currently -24.16% below its historical high of $310.10 million

    Market Cap Sector Percentile

    50.68%
    FENC market cap is higher than 50.68% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.49%
    FENC shares outstanding is up +1.49% year-on-year

    Shares Outstanding 3-Year Change

    +6.07%
    FENC shares outstanding is up +6.07% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.96
    FENC beta is 0.96

    200-day SMA

    $7.53
    FENC price is currently +12.19% above its 200-day simple moving average

    50-day SMA

    $8.86
    FENC price is currently -4.61% below its 50-day simple moving average

    14-Day RSI

    48.26
    FENC 14-day relative strength index is 48.26

    Volume

    1.01
    FENC 30-day relative volume is 1.01

    ATR

    $0.42
    FENC average true range is $0.42

    10-day Historical Volatility

    50.77%
    FENC 10-day historical volatility is 50.77%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $47.54M
    FENC annual revenue is $47.54 million

    Revenue Analysts Estimate

    $44.50M
    FENC annual revenue is currently +6.82% higher than the consensus analysts' forecast

    Revenue 1-Year Change

    +123.69%
    FENC annual revenue is up +123.69% year-on-year

    Revenue Sector Percentile

    61.04%
    FENC annual revenue is higher than 61.04% of companies in Healthcare sector

    EPS

    EPS

    -$0.02
    FENC annual earnings per share is -$0.02

    EPS Analysts Estimate

    $0.30
    FENC annual earnings per share is currently -105.33% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +97.35%
    FENC annual earnings per share is up +97.35% year-on-year

    EPS Sector Percentile

    80.19%
    FENC annual earnings per share is higher than 80.19% of companies in Healthcare sector

    Profit

    Gross Profit

    $44.35M
    FENC annual gross profit is $44.35 million

    Gross Margin

    93.30%
    FENC annual gross profit margin is 93.30%

    Operating Profit

    $2.57M
    FENC annual operating income is $2.57 million

    Operating Margin

    5.40%
    FENC annual operating profit margin is 5.40%

    Net Income

    -$436.00K
    FENC annual net profit is -$436.00 thousand

    Net Margin

    -0.92%
    FENC annual net profit margin is -0.92%

    Expenses

    Total Expenses

    $47.97M
    FENC annual total expenses is $47.97 million

    Operating Expenses

    $41.79M
    FENC annual total operating expenses is $41.79 million

    Cost Of Goods Sold

    $3.18M
    FENC annual cost of goods sold is $3.18 million

    Selling, General & Administrative Expenses

    $0.00
    FENC annual SG&A is $0.00

    Depreciation & Amortization

    -
    FENC annual D&A value is unknown

    Interest Expense

    $0.00
    FENC annual interest expense is $0.00

    Income Tax

    $365.00K
    FENC annual income tax is $365.00 thousand

    EBIT & EBITDA

    EBIT

    $2.57M
    FENC annual earnings before interest & taxes is $2.57 million

    EBITDA

    $2.57M
    FENC annual EBITDA is $2.57 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $44.95M
    FENC annual total assets is $44.95 million

    Non Current Assets

    $924.00K
    FENC annual long term assets is $924.00 thousand

    Current Assets

    $44.12M
    FENC annual total current assets is $44.12 million

    Cash and Cash Equivalents

    $26.63M
    FENC annual cash & cash equivalents is $26.63 million

    Accounts Receivable

    $12.88M
    FENC annual accounts receivable is $12.88 million

    Inventory

    $1.06M
    FENC annual inventory is $1.06 million

    Liabilities

    Total Liabilities

    $50.82M
    FENC annual total liabilities is $50.82 million

    Long Term Liabilities

    $43.90M
    FENC annual total long term liabilities is $43.90 million

    Current Liabilities

    $6.92M
    FENC annual current liabilities is $6.92 million

    Accounts Payable

    $3.24M
    FENC annual accounts payable is $3.24 million

    Debt

    Total Debt

    $18.07M
    FENC annual total debt is $18.07 million

    Total Debt 1-Year Change

    -39.23%
    FENC annual total debt is down -39.23% year-on-year

    Long Term Debt

    $18.07M
    FENC annual long term debt is $18.07 million

    Short Term Debt

    $2000.00
    FENC annual short term debt is $2000.00

    Equity & Capital

    Shareholders Equity

    -$5.87M
    FENC annual stockholders equity is -$5.87 million

    Book Value

    -$5.87M
    FENC annual book value is -$5.87 million

    Retained Earnings

    -$219.68M
    FENC annual retained earnings is -$219.68 million

    Working Capital

    $37.20M
    FENC annual working capital is $37.20 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    $26.98M
    FENC annual cash from operations is $26.98 million

    Cash From Operations 1-Year Change

    +257.38%
    FENC annual cash from operations is up +257.38% year-on-year

    Cash From Investing

    $0.00
    FENC annual cash from investing is $0.00

    Cash From Investing 1-Year Change

    0%
    FENC annual cash from investing has remained unchanged year-on-year

    Cash From Financing

    -$13.62M
    FENC annual cash from financing is -$13.62 million

    Cash From Financing 1-Year Change

    -305.11%
    FENC annual cash from financing is down -305.11% year-on-year

    CAPEX

    CAPEX

    $0.00
    FENC annual capital expenditures is $0.00

    CAPEX 1-Year Change

    0%
    FENC annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free Cash Flow

    $26.98M
    FENC annual free cash flow is $26.98 million

    Free Cash Flow 1-Year Change

    +257.38%
    FENC annual free cash flow is up +257.38% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    93.30%
    FENC annual gross profit margin is 93.30%

    Operating Margin

    5.40%
    FENC annual operating profit margin is 5.40%

    Net Margin

    -0.92%
    FENC annual net profit margin is -0.92%

    ROA & ROE

    ROA

    -1.21%
    FENC annual return on assets is -1.21%

    ROE

    7.43%
    FENC annual return on equity is 7.43%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    FENC price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    FENC price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    -31.51
    FENC price to book ratio is -31.51

    PB Ratio Sector Percentile

    2.22%
    FENC price to book ratio is higher than 2.22% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    7.06
    FENC price to sales ratio is 7.06

    PS Ratio Sector Percentile

    63.84%
    FENC price to sales ratio is higher than 63.84% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $234.57M
    FENC enterprise value is $234.57 million

    Enterprise Value Sector Percentile

    55.11%
    FENC enterprise value is higher than 55.11% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -24.24
    FENC EV/EBITDA is -24.24

    EV/EBITDA Sector Percentile

    6.44%
    FENC EV/EBITDA is higher than 6.44% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    6.38
    FENC annual current ratio is 6.38

    Quick Ratio

    6.22
    FENC annual quick ratio is 6.22

    Leverage

    Debt To Equity

    -3.08
    FENC annual debt to equity ratio is -3.08

    Interest Coverage Ratio

    -
    FENC annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    1
    FENC piotroski f-score is 1

    Altman Z-Score

    -1.83
    FENC altman z-score is -1.83

    Analyst ratings

    Recent major analysts updates

    Aug 21, 25 HC Wainwright & Co.
    Buy
    Aug 15, 25 Craig-Hallum
    Buy
    May 20, 25 HC Wainwright & Co.
    Buy
    May 14, 25 Craig-Hallum
    Buy
    Mar 11, 25 HC Wainwright & Co.
    Buy
    Dec 17, 24 HC Wainwright & Co.
    Buy
    Aug 22, 24 HC Wainwright & Co.
    Buy
    Aug 14, 24 Craig-Hallum
    Buy
    May 15, 24 HC Wainwright & Co.
    Buy
    May 15, 24 Craig-Hallum
    Buy

    Institutional Ownership

    Screeners with FENC included

    Growing Shares Outstanding
    US stocks
    Most recommended stocks
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Best performing stocks last 12 months
    • What is the ticker symbol for Fennec Pharmaceuticals Inc.?
    • Does Fennec Pharmaceuticals Inc. pay dividends?
    • What sector is Fennec Pharmaceuticals Inc. in?
    • What industry is Fennec Pharmaceuticals Inc. in?
    • What country is Fennec Pharmaceuticals Inc. based in?
    • When did Fennec Pharmaceuticals Inc. go public?
    • Is Fennec Pharmaceuticals Inc. in the S&P 500?
    • Is Fennec Pharmaceuticals Inc. in the NASDAQ 100?
    • Is Fennec Pharmaceuticals Inc. in the Dow Jones?
    • When was Fennec Pharmaceuticals Inc.'s last earnings report?
    • When does Fennec Pharmaceuticals Inc. report earnings?

    What is the ticker symbol for Fennec Pharmaceuticals Inc.?

    The ticker symbol for Fennec Pharmaceuticals Inc. is NASDAQ:FENC

    Does Fennec Pharmaceuticals Inc. pay dividends?

    No, Fennec Pharmaceuticals Inc. does not pay dividends

    What sector is Fennec Pharmaceuticals Inc. in?

    Fennec Pharmaceuticals Inc. is in the Healthcare sector

    What industry is Fennec Pharmaceuticals Inc. in?

    Fennec Pharmaceuticals Inc. is in the Biotechnology industry

    What country is Fennec Pharmaceuticals Inc. based in?

    Fennec Pharmaceuticals Inc. is headquartered in United States

    When did Fennec Pharmaceuticals Inc. go public?

    Fennec Pharmaceuticals Inc.'s initial public offering (IPO) was on September 15, 2017

    Is Fennec Pharmaceuticals Inc. in the S&P 500?

    No, Fennec Pharmaceuticals Inc. is not included in the S&P 500 index

    Is Fennec Pharmaceuticals Inc. in the NASDAQ 100?

    No, Fennec Pharmaceuticals Inc. is not included in the NASDAQ 100 index

    Is Fennec Pharmaceuticals Inc. in the Dow Jones?

    No, Fennec Pharmaceuticals Inc. is not included in the Dow Jones index

    When was Fennec Pharmaceuticals Inc.'s last earnings report?

    Fennec Pharmaceuticals Inc.'s most recent earnings report was on August 14, 2025

    When does Fennec Pharmaceuticals Inc. report earnings?

    The next expected earnings date for Fennec Pharmaceuticals Inc. is November 6, 2025
    On this page